Washington § 48.43.410 Prescription drug utilization management—Clinical review criteria—Requirement to be evidence-based and updated regularly.(Effective until January 1, 2027.)

Washington Statutes

§ 48.43.410 — Prescription drug utilization management—Clinical review criteria—Requirement to be evidence-based and updated regularly.(Effective until January 1, 2027.)

Washington § 48.43.410

Title 48INSURANCE

Ch. 48.43INSURANCE REFORM

This text of Washington § 48.43.410 (Prescription drug utilization management—Clinical review criteria—Requirement to be evidence-based and updated regularly.(Effective until January 1, 2027.)) is published on Counsel Stack Legal Research, covering Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Wash. Rev. Code § 48.43.410 (2026).

Text

For health plans delivered, issued for delivery, or renewed on or after January 1, 2021, clinical review criteria used to establish a prescription drug utilization management protocol must be evidence-based and updated on a regular basis through review of new evidence, research, and newly developed treatments.

Rules — 2019 c 171: See note following RCW 48.43.420 .

For health plans delivered, issued for delivery, or renewed on or after January 1, 2021, clinical review criteria used to establish a prescription drug utilization management protocol must be evidence-based and updated on a regular basis through review of new evidence, research, and newly developed treatments. For prescription drugs prescribed to treat mental health or substance use disorder conditions, clinical review criteria

Free access — add to your briefcase to read the full text and ask questions with AI

For health plans delivered, issued for delivery, or renewed on or after January 1, 2021, clinical review criteria used to establish a prescription drug utilization management protocol must be evidence-based and updated on a regular basis through review of new evidence, research, and newly developed treatments.

Rules — 2019 c 171: See note following RCW 48.43.420 .

For health plans delivered, issued for delivery, or renewed on or after January 1, 2021, clinical review criteria used to establish a prescription drug utilization management protocol must be evidence-based and updated on a regular basis through review of new evidence, research, and newly developed treatments. For prescription drugs prescribed to treat mental health or substance use disorder conditions, clinical review criteria must meet the requirements of RCW 48.43.766 .

Effective date — 2025 c 227 ss 1-8: See note following RCW 48.43.766 .

Findings — Intent — Rules — 2025 c 227: See notes following RCW 48.43.766 .

Rules — 2019 c 171: See note following RCW 48.43.420 .